MedPath

Evaluation of the Skin Irritation and Skin Sensitization Potential by Human Repeat Insult Patch Test (HRIPT).

Not Applicable
Completed
Registration Number
CTRI/2024/02/063099
Lead Sponsor
Himalaya Wellness Company
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
240
Inclusion Criteria

1.Age: 18-65 years (both inclusive) at the time of consent.

2.Sex: Males and non-pregnant/non-lactating females.

3.Subjects having Phototype III to V

4.Subjects having apparently healthy skin on test area

5.Subjects for whom the investigator considers that the compliance will be correct.

Exclusion Criteria

1.Subject who is pregnant or lactating.

2.Subjects having skin irritation, blemishes, excessive hair, moles, pigmentation, pimples, marks (e.g., tattoos (within the previous 3 months), scars, sunburn), open wounds, cuts, abrasions, irritation symptoms or any dermatological condition on the test site(s) that can interfere with the reading.

3.Subjects with dermatological infection/pathology on the level of studied area.

4.Subjects with hypersensitivity, allergy antecedent (to any cosmetic product, raw material, hair dye).

5.Subjects with any clinically significant systemic or cutaneous disease, which may interfere with study procedures.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the test products for their skin irritation and skin sensitization potential by repetitive applications on the skin of human subjects.Timepoint: Diagnostic Patch Time points: 0hour and 48 hours. <br/ ><br> <br/ ><br>Induction Phase: 0 hr, 24, 48, 72, 96, 120, 144, 168, 192, 216, 240, 264, 288, 312, 336, 360, 384, 408, 432 hours. <br/ ><br> <br/ ><br>Resting Period of 14 days. <br/ ><br> <br/ ><br>Challenge phase: 24 hours, 48 hours and 72 hours.
Secondary Outcome Measures
NameTimeMethod
ot ApplicableTimepoint: Not Applicable
© Copyright 2025. All Rights Reserved by MedPath